A screen of 350 combination therapies with 177Lu-DOTATATE reveal distinct differences to EBRT and novel action of CDK4/6 inhibitors (2020)

First Author: ONeill Edward

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 61

Parent Publication: JOURNAL OF NUCLEAR MEDICINE

ISSN: 0161-5505